ICE
57
2
CAT
59
4
RL
72
3
MHK
46
3
CSX
57
4
V
56
2
TDC
47
-39
PEG
50
4
XYL
35
4
PCG
77
3
AZO
50
2
ESS
56
5
PPL
54
5
NRG
67
8
DG
27
-2
ADBE
43
3
SLG
66
4
VMC
62
5
RRC
50
4
GME
57
2
ICE
57
2
CAT
59
4
RL
72
3
MHK
46
3
CSX
57
4
V
56
2
TDC
47
-39
PEG
50
4
XYL
35
4
PCG
77
3
AZO
50
2
ESS
56
5
PPL
54
5
NRG
67
8
DG
27
-2
ADBE
43
3
SLG
66
4
VMC
62
5
RRC
50
4
GME
57
2
Financhill
Back

Evaxion Biotech AS 10K Form

Sell
6

EVAX
Evaxion Biotech AS

Last Price:
2.61
Seasonality Move:
-39.53%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive EVAX News And Ratings

See the #1 stock for the next 7 days that we like better than EVAX

EVAX Financial Statistics

Sales & Book Value

Annual Sales: $73K
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $0.01
Price / Book: 196.74

Profitability

EPS (TTM): -2.80000
Net Income (TTM): $-11.46M
Gross Margin: --
Return on Equity: 0%
Return on Assets: -69.51%

Evaxion Biotech AS Earnings Forecast

Key Evaxion Biotech AS Financial Ratios

  • The Research & Development expenses have been 16,323.29% of Revenue.
  • The Interest Expense is -4.05% of Operating Income.
  • The Net Earning history of EVAX is -30,308.22% of Total Revenues.
  • Per Share Earnings over the last 6 years have been positive in 2 years.

Evaxion Biotech AS Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: EVAX
Website: evaxion-biotech.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

EVAX Technical Analysis vs Fundamental Analysis

Sell
6
Evaxion Biotech AS (EVAX) is a Sell

Is Evaxion Biotech AS a Buy or a Sell?